Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial
Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.

Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUpdated revision from v3.4.1 to v3.4.2; no visible changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to content or functionality are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded a glossary toggle and updated metadata labels to include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.3%

- Check42 days agoChange Detected- Revision updated from v3.3.3 to v3.3.4; no changes to the study data, eligibility criteria, or results.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision v3.3.2 has been added and v3.2.0 has been removed.SummaryDifference0.1%

Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.